LAB SEC Filings: 8-K, 10-Q, S-3 & 424B – Standard BioTools

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 6, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 16, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 15, 2025

News

TYPE

HEADLINE

FILED AT

8-K

ARCHIMED Completes Acquisition of Standard BioTools’ Microfluidics Business, Rebranded as Biomark Scientific

Nov 3, 2026

8-K

Standard BioTools Agrees to Sell Microfluidics Business to ARCHIMED

Oct 5, 2026

8-K

Standard BioTools Agrees to Sell Mass Cytometry Business to Element Biosystems for $5.5M, Replacing Multiplex Bio Agreement

Sep 30, 2026

8-K

Standard BioTools Reports Second Quarter 2026 Financial Results and Provides Merger Update

Aug 5, 2026

8-K/A

Share and Asset Purchase Agreement Filed for Mass Cytometry Business Acquisition by Multiplex Bio Inc.

Jul 29, 2026

8-K

Standard BioTools Announces Sale of Mass Cytometry Business and $30 Million Buyout of Illumina Contingent Payments

Jul 28, 2026

Prospectus

TYPE

HEADLINE

FILED AT

425

Form 425 - Prospectuses and communications, business combinations

Nov 3, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 1,551,769,528

Oct 30, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 537,687,757

Oct 21, 2026

425

Form 425 - Prospectuses and communications, business combinations

Oct 5, 2026

425

Form 425 - Prospectuses and communications, business combinations

Sep 30, 2026

425

Form 425 - Prospectuses and communications, business combinations

Jul 29, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Oct 21, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Oct 9, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Sep 9, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 5, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 5, 2026

S-4

Centerview Partners Consents to Inclusion of Fairness Opinion in Standard BioTools and Treeline Biosciences Merger Proxy EFFECTIVE, DATED 2026-10-21

Jul 20, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Carey Thomas D. (Reporting)

Nov 5, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Oct 21, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Oct 9, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Sep 9, 2026

Mackay Sean (Reporting)

Aug 24, 2026

Kim Hanjoon Alex (Reporting)

Aug 24, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 22, 2026

Form SD - Specialized disclosure report

May 29, 2026

Form SD - Specialized disclosure report

Jun 2, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 28, 2024

CORRESP

Form CORRESP - Correspondence

Jun 25, 2024

LETTER

Form UPLOAD - SEC-generated letter

Jun 25, 2024

Standard BioTools Inc. LAB · SEC Filings